Home » Topics » Medical technology

Medical technology
RSS

British Biotech's Marimistat Fails In Promising Indication

Feb. 14, 2001

British Biotech's Marimistat Fails In Promising Indication

Feb. 14, 2001

French Advancing Legislation To Allow Therapeutic Cloning

Feb. 14, 2001

By James Etheridge

Genta Moves Genasense Into Phase III For Multiple Myeloma

Feb. 14, 2001

Other News To Note

Feb. 13, 2001

Oxford Glyco Plans Gaucher NDA On Cerezyme Comparison Study

Feb. 13, 2001

Third Wave Prices IPO At $11 For Gross Proceeds Of $82.5M

Feb. 13, 2001

Microcide Puts $35M In Securities On Shelf For Future Financings

Feb. 13, 2001

Celera, Public Consortium Jointly Publish Human Genome Cloning

Feb. 13, 2001

Pace Of Discovery Expected To Increase With Sequence Data

Feb. 13, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...